Beating Cancer

Starts With Knowing You Have It

Finding cancer early is key to improve treatment outcomes and survival.
0

of cancer deaths

are caused by cancers not commonly screened for.

What if you could find cancer early enough to make a difference?

Our multi-cancer early detection test detects a cancer signal across more than 50 types of cancer, many of which are not commonly screened for today. With a simple blood draw, it provides early detection insights that help you be proactive about your health.
This test does not detect all cancers nor does it measure your genetic risk of developing cancer in the future. It should be used in addition to routine screening tests your healthcare provider recommends.

Responsible for 1 of every 6 deaths

In 2020, 10 million people died of cancer

About 600,000 cancer deaths occur in the U.S. each year

OUR KEY BENEFITS

Early cancer detection

Detects many cancers not commonly screened for today, to allow for earlier treatment.

Testing with ease

Completed with a simple blood draw.

Actionable results

If a cancer signal is found, the results can point to where in the body the cancer is coming from with high accuracy.

People aged 50
and above have a

0

increased risk of cancer.

Who can benefit?

This test is recommended for use in adults with an elevated risk for cancer, such as those aged 50 or older. This test is intended to be used in addition to, and not replace, other cancer screening tests your healthcare provider recommends.
Not all cancers can be detected by the Galleri test. Your healthcare provider will discuss appropriate follow-up testing to confirm if cancer is present.

Types of cancer detected

Adrenal Cortical Carcinoma
Ampulla of Vater
Anus
Appendix, Carcinoma
Bile Ducts, Distal
Bile Ducts, Intrahepatic
Bile Ducts, Perihilar
Bladder, Urinary
Bone
Breast
Cervix
Colon and Rectum
Esophagus and Esophagogastric Junction 
Gallbladder
Gastrointestinal Stromal Tumor
Gestational Trophoblastic Neoplasms
Kidney
Larynx
Leukemia

Liver
Lung
Lymphoma (Hodgkin and Non-Hodgkin) 
Melanoma of the Skin
Merkel Cell Carcinoma
Mesothelioma, Malignant Pleural 
Nasal Cavity and Paranasal Sinuses
Nasopharynx
Neuroendocrine Tumors of the Appendix 
Neuroendocrine Tumors of the Colon and Rectum 
Neuroendocrine Tumors of the Pancreas 
Oral Cavity
Oropharynx (HPV-Mediated, p16+)
Oropharynx (p16-) and Hypopharynx
Ovary, Fallopian Tube and Primary Peritoneum 
Pancreas, exocrine
Penis

Plasma Cell Myeloma and Plasma Cell Disorders 
Prostate 
Small Intestine
Soft Tissue Sarcoma of the Abdomen and Thoracic Visceral Organs 
Soft Tissue Sarcoma of the Head and Neck
Soft Tissue Sarcoma of the Retroperitoneum
Soft Tissue Sarcoma of the Trunk and Extremities
Soft Tissue Sarcoma Unusual Histologies and Sites
Stomach
Testis 
Ureter, Renal Pelvis
Uterus, Carcinoma and Carcinosarcoma 
Uterus, Sarcoma
Vagina
Vulva 

When cancers are diagnosed early

before they have had the chance to spread, the overall 5-year survival rate is:

before they have had the chance to spread, the overall 5-year survival rate is:

4x

HIGHER

than when diagnosed in later stages

than when diagnosed in later stages

Defeating cancer starts with early detection

Today, the majority of cancers are found too late, when the prognosis is often poor and treatment options are limited.

The earlier that cancer is diagnosed, the greater the chance of successful treatment and survival.
CONTACT US

ACCESS TO THE BEST CARE

IS A MUST

The lessons learned during the 2020 pandemic taught us access to the best care is not an option, but a requirement.

Contact us to learn how to join to protect your health and the health of those you love.

    CALL THE BEST CONCIERGE MEDICINE EXPERTS IN MIAMI